Back to Results
First PageMeta Content
Organic chemistry / Tacrolimus / Mycophenolic acid / Kidney transplantation / Daclizumab / BK virus / Immunosuppressants / Medicine / Chemistry


Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Prograf
Add to Reading List

Document Date: 2010-07-01 11:11:57


Open Document

File Size: 152,77 KB

Share Result on Facebook

Company

Astellas Pharma Europe B.V. / Figure 1 Group / Lo4AD02 Pharmaceutical / /

Country

Germany / France / Sweden / Ireland / /

/

Event

Product Issues / Product Recall / /

IndustryTerm

pharmaceutical formulation / immunosuppressive medicinal products / medicinal product / medicinal products / /

MedicalCondition

Injury poisoning / hypertension / end stage kidney disease / Skin disorders / fewer patients developing glucose intolerance / procedural disorders / diabetes / treatment Chronic / subcutaneous disorders / lymphatic disorders / Infection / renal dysfunction / /

MedicalTreatment

renal transplantation / kidney transplantation / renal transplant / /

Person

David Lyons / Statistical Methods Prograf (Tacrolimus) / /

/

Position

incomplete data Fisher / /

Product

methylprednisolone / Zenapax / Prednisolone / corticosteroid / events Steroid / patients experiencing rejection episodes Steroid / organ system Steroid / Study week Steroid / Prograf / trial comparing early / Steroid / /

ProvinceOrState

Arkansas / /

Technology

transplantation / /

SocialTag